» Articles » PMID: 12033863

Pd/P(t-Bu)(3): a Mild and General Catalyst for Stille Reactions of Aryl Chlorides and Aryl Bromides

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2002 May 30
PMID 12033863
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Pd/P(t-Bu)(3) serves as an unusually reactive catalyst for Stille reactions of aryl chlorides and bromides, providing solutions to a number of long-standing challenges. An unprecedented array of aryl chlorides can be cross-coupled with a range of organotin reagents, including SnBu(4). Very hindered biaryls (e.g., tetra-ortho-substituted) can be synthesized, and aryl chlorides can be coupled in the presence of aryl triflates. The method is user-friendly, since a commercially available complex, Pd(P(t-Bu)(3))(2), is effective. Pd/P(t-Bu)(3) also functions as an active catalyst for Stille reactions of aryl bromides, furnishing the first general method for room-temperature cross-couplings.

Citing Articles

Pd-Catalyzed Cross-Couplings: On the Importance of the Catalyst Quantity Descriptors, mol % and ppm.

Horbaczewskyj C, Fairlamb I Org Process Res Dev. 2022; 26(8):2240-2269.

PMID: 36032362 PMC: 9396667. DOI: 10.1021/acs.oprd.2c00051.


Palladium-catalyzed chemoselective direct α-arylation of carbonyl compounds with chloroaryl triflates at the C-Cl site.

Chen Z, Gu C, Yuen O, So C Chem Sci. 2022; 13(17):4762-4769.

PMID: 35655875 PMC: 9067565. DOI: 10.1039/d1sc06701j.


Solvent coordination to palladium can invert the selectivity of oxidative addition.

Elias E, Rehbein S, Neufeldt S Chem Sci. 2022; 13(6):1618-1628.

PMID: 35282616 PMC: 8827013. DOI: 10.1039/d1sc05862b.


Late-Stage Heteroarylation of Hetero(aryl)sulfonium Salts Activated by α-Amino Alkyl Radicals.

Alvarez E, Karl T, Berger F, Torkowski L, Ritter T Angew Chem Int Ed Engl. 2021; 60(24):13609-13613.

PMID: 33835680 PMC: 8251951. DOI: 10.1002/anie.202103085.


Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.

Friggeri L, Hargrove T, Wawrzak Z, Guengerich F, Lepesheva G J Med Chem. 2019; 62(22):10391-10401.

PMID: 31663733 PMC: 6881533. DOI: 10.1021/acs.jmedchem.9b01485.